Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
Use our account feature to register for a free CLI account. Your new account will allow you to bookmark and organize articles and research for easy reference later - making it simple to keep track of the research that's important to you!
Register / Sign in
close-panel

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Get Notifications

Sign up to receive email updates from Charlotte Lozier Institute.

This field is for validation purposes and should be left unchanged.

Become A Defender of Life

Your donation helps us continue to provide world-class research in defense of life.

DONATE

Charlotte Lozier Institute

Phone: 202-223-8073
Fax: 571-312-0544

2776 S. Arlington Mill Dr.
#803
Arlington, VA 22206

Life & the LawFetal Tissue, Stem Cells & Bioethics

Grants for Stem Cell Research Favor Ethical Approaches

The Maryland Stem Cell Research Fund (MSCRF) has awarded two rounds of grants since the Charlotte Lozier Institute last analyzed the Fund’s pattern of grant making for stem cell research, in the fall of 2013.[1]

 

That study found that since MSCRF first began awarding grants in 2007, its pattern of giving shifted over the years from strongly favoring projects focusing on ethically contentious human embryonic stem cell research (hESCR) to projects focusing on ethically non-contentious adult stem cells and other non-embryonic stem cell research.  Thus, for its first round of grants in 2007, MSRF awarded just $2.4 million to 4 projects using adult stem cells, but more than twice that amount—$5.21 million—for 11 projects using human embryonic stem cells (hESCs).

 

But by 2013 this pattern had been dramatically reversed: fully 90 percent—28 of 31 grants—went toward non-embryonic stem cell research projects, while only one hESCR project received funding.[2]

 

MSCRF’s most recent rounds of grants, for 2014 and 2015, strongly reinforce this pattern.

 

In 2014, MSCRF awarded just over $10 million in grants but did not fund any research project using hESCs alone.  Of 30 projects to receive grants, two used both hESCS and iPSCs, while three others went for research projects to improve techniques for conducting stem cell research generically.  The remaining 25 grants went to adult, induced pluripotent and other non-embryonic stem cell research projects.

 

In 2015, MSCRF awarded over $9 million in grants to 29 research projects.  A clear majority of those grants—25 total—went to research projects using adult and non-embryonic induced pluripotent stem cells (iPSCs), while only two went to projects using hESCs.[3]

 

As noted in Lozier’s previous study of MSCRF grant-making, Maryland is home to the Johns Hopkins School of Medicine, one of the nation’s leading institutions for stem cell research.  Thus, how Maryland chooses to fund stem cell research can be an important indicator of where the field in general is headed.

 

And that direction is clearly toward ethically non-contentious adult and other non-embryonic stem cell research and away from the morally problematic human embryonic stem cell research.

 

Gene Tarne is Senior Analyst for the Charlotte Lozier Institute.


[1] Maryland is one of a handful of states currently providing state funds for embryonic (and other types of) stem cell research. The others are California, New York, Connecticut and, most recently, Minnesota, which approved such funding in 2014. Programs in New Jersey and Illinois to provide state funding for such research have ended.

 

[2] Of the remaining two grants, one was for a project using fetal tissue, and the other for one using both embryonic and non-embryonic stem cells.

 

[3] The other two projects were 1) to create a human mouse chimera using both hESCs and iPSCs and 2) to improve technology that could be applied to any stem cell research.

Latest Posts

October 4, 2024 Scientists Sue Publisher Over Retractions Of Studies Showing Dangers Of Abortion Pills October 4, 2024 Scientists Sue Over ‘Discriminatory’ Retraction Of Studies Exposing Abortion Pill Dangers October 3, 2024 ADF, Consovoy McCarthy sue academic publisher for politically motivated retractions ADF, Consovoy McCarthy sue academic publisher for politically motivated retractions

You Might Also Be Interested In

Fact Sheet: Third Trimester Abortion and “Abortion Up to Birth”

September 20, 2024
Please login to bookmarkClose

Data shows Texas doctors perform abortions to save life of the mother, despite claims from politicians, media

September 15, 2024
Please login to bookmarkClose

Fact Sheet: Are Pro-Life State Laws Preventing Pregnant Women from Receiving Emergency Care?

September 13, 2024
Please login to bookmarkClose

Become A Defender of Life

Your donation helps us continue to provide
world-class research in defense of life.

BECOME A PARTNER
cta-image